ATPC (Agape ATP) Earnings per share for the last four quarters

Agape ATP Corp. (ATPC) - corporate logo

This chart of current market value demonstrates that Agape ATP Corporation (ATPC) has an EPS TTM of 93.60. Agape ATP Corporation (ATPC) generates revenue through the sale of dietary supplements and wellness services for residents of Southeast Asia. The business relies on the implementation of rapid medical tests to maintain customer retention amid fierce competition. A stable backdrop is provided by localization in Malaysia, which minimizes the impact of global trade conflicts.

ATPC agapeatpgroup.com Net earnings per share (EPS TTM) (11/23/2025 - 11/18/2026)

ATPC (agapeatpgroup.com): analytical breakdowns and indicator data

- price and consensus price forecast:
- business market valuation indicators:
Fundamental company valuation:ATPC (Agape ATP Corp.)
Core merchandise of Agape ATP Corporation

Agape ATP Corporation (ATPC) operates within Malaysia's healthcare sector, where regulatory risks and limited capital constrain global scaling. Analyzing the annual EPS (TTM) growth rate, an investor can observe the change in rolling earnings over four quarters, reflecting the business's ability to generate income amid the Fed's tight monetary policy, although sharp peaks may signal a stock overvaluation.

Competitor analysis

Net earnings per one share for the last twelve months Ascendis Pharma Inc.|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Therapeutics|Net earnings per share (EPS TTM) MTSR|Earnings per share for the last twelve months MLTX (MoonLake Immunotherapeutics AG)|Earnings per share for the last twelve months crinetics.com CRNX|NewAmsterdam Pharma Corp (NAMS) - Net earnings per one share for the last twelve months|SLNO - Earnings per share for the last twelve months|FOLD: Earnings per share for the last twelve months|ETNB: Net earnings per share (EPS TTM)|AGIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Structure Corp|MiMedx Corp (MDXG) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months rezolutebio.com (RZLT)|Net earnings per share for the last 12 months lexpharma.com LXRX|Net earnings per share (EPS TTM) MBX (MBX Biosciences)|Altimmune Corp - Earnings per share for the last twelve months|Aardvark Therapeutics Inc. - Net earnings per share (EPS TTM)|SGMT - Net earnings per share (EPS TTM)|BioAge Labs (BIOA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months biomeafusion.com (BMEA)|Earnings per share for the last twelve months Quince Therapeutics, Inc.|Net earnings per share for the last 12 months Fractyl (GUTS)|Net earnings per share for the last 12 months VTVT (vTv Therapeutics Inc.)|Net earnings per share for the last four quarters Pluri Inc|Net earnings per share (EPS TTM) SYBX (Synlogic Corp)|Net earnings per share for the last four quarters lipocine.com (LPCN)|MTNB - Earnings per share for the last twelve months|Earnings per share for the trailing year SPRB (Spruce Biosciences)|GLTO (Galecto Corp) - Net earnings per share for the last 12 months|Carmell Corp - Earnings per share for the trailing year|LUMO (Lumos Therapeutics) - Net earnings per share (EPS TTM)|ONVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) RDUS